Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...
Treatment with pimitespib was associated with stable disease in two-thirds of patients with advanced gastrointestinal stromal ...
A new study highlights the role of inflammatory biomarkers, mitotic index, and imatinib adherence in predicting survival ...
You have full access to this article via your institution. Figure 1: A family with multiple GISTs and mutation of the KIT gene.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results